Targeting the Pathways to Better Health
Our Mission
Intellikine is discovering and developing innovative, small molecule drugs that target signal transduction networks for the treatment of cancer, inflammation and autoimmune diseases. Learn More
JP Morgan Healthcare Conference
January 11-14, 2010 / San Francisco
Allicense 2010
May 25-26, 2010 / San Francisco
Learn More
Our pipeline programs include both novel isoform-selective and pathway-selective inhibitors of members of the PI3K/Akt/mTOR signaling network.
Learn More
Intellikine announces three-dimensional crystal structure of
important drug target.
Learn More